Imatinib-d8
| Catalog Number | Pack Size | List Price* | Promo Price* | Quantity | |
|---|---|---|---|---|---|
| HY-15463S-1MG | 1 mg | 602,00 | 373,30 | Add | |
| HY-15463S-5MG | 5 mg | 1'505,00 | 933,10 | Add | |
| HY-15463S-1ML | 10mM/1mL | 1'659,00 | 1'028,60 | Add | |
| HY-15463S-10MG | 10 mg | 2'474,00 | 1'533,90 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Promotion runs until 31.12.2026Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
STI571-d8; CGP-57148B-d8
Imatinib-d8 is a deuterium labeled Imatinib (STI571) . Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity[1][2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Application | Isotope-labeled compound |
| Regulatory Status | RUO |
| Research Field | Cancer |
| Format | Solubility: 10 mM in DMSO;DMSO : 12.5mg/mL (ultrasonic) ;H2O : 10mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.88% |
| Molecular Formula | C29H23D8N7O |
| Molecular Weight | 501.65 |
| CAS-Number | 1092942-82-9 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Disclaimer | Deuterated products takes approx 1 week longer delivery time |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
